These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 21135522)

  • 1. HPV test results stratify risk for histopathologic follow-up findings of high-grade cervical intra-epithelial neoplasia in women with low-grade squamous intra-epithelial lesion Pap results.
    Heider A; Austin RM; Zhao C
    Acta Cytol; 2011; 55(1):48-53. PubMed ID: 21135522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Follow-up with histopathology and HPV testing on LSIL cytology in China's largest academic woman's hospital.
    Tao X; Zhang H; Zhang H; Xiao J; Li J; Zhou X; Wang L; Zhao C
    Cancer Cytopathol; 2019 Apr; 127(4):258-266. PubMed ID: 30892831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-grade squamous intraepithelial lesion/cannot exclude high-grade squamous intraepithelial lesion (LSIL-H) is a unique category of cytologic abnormality associated with distinctive HPV and histopathologic CIN 2+ detection rates.
    Barron S; Li Z; Austin RM; Zhao C
    Am J Clin Pathol; 2014 Feb; 141(2):239-46. PubMed ID: 24436272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distribution of human papillomavirus types in ThinPrep Papanicolaou tests classified according to the Bethesda 2001 terminology and correlations with patient age and biopsy outcomes.
    Evans MF; Adamson CS; Papillo JL; St John TL; Leiman G; Cooper K
    Cancer; 2006 Mar; 106(5):1054-64. PubMed ID: 16421920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immediate histopathologic follow-up of cervista and aptima high-risk HPV assays in women with LSIL cytology.
    Zhang H; Varma KR; Han M; Matsko J; Zhao C
    Cancer Cytopathol; 2018 Aug; 126(8):525-532. PubMed ID: 29797678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is the human papillomavirus test in combination with the Papanicolaou test useful for management of patients with diagnoses of atypical squamous cells of undetermined significance/low-grade squamous intraepithelial lesions?
    Lee NW; Kim D; Park JT; Kim A
    Arch Pathol Lab Med; 2001 Nov; 125(11):1453-7. PubMed ID: 11698001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significance of high-risk human papillomavirus DNA detection in women 50 years and older with squamous cell papanicolaou test abnormalities.
    Zhao C; Zhao S; Heider A; Austin RM
    Arch Pathol Lab Med; 2010 Aug; 134(8):1130-5. PubMed ID: 20670132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Triage of women with ASCUS and LSIL on Pap smear reports: management by repeat Pap smear, HPV DNA testing, or colposcopy?
    Ferris DG; Wright TC; Litaker MS; Richart RM; Lorincz AT; Sun XW; Borgatta L; Buck H; Kramer L; Rubin R
    J Fam Pract; 1998 Feb; 46(2):125-34. PubMed ID: 9487318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Women >or=30 years of age with low grade squamous intraepithelial lesion (LSIL) have low positivity rates when cotested for high-risk human papillomavirus: should we reconsider HPV triage for LSIL in older women?
    Thrall MJ; Smith DA; Mody DR
    Diagn Cytopathol; 2010 Jun; 38(6):407-12. PubMed ID: 19894254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation of histopathologic follow-up findings with vaginal human papillomavirus and low-grade squamous intraepithelial lesion Papanicolaou test results.
    Bansal M; Austin RM; Zhao C
    Arch Pathol Lab Med; 2011 Dec; 135(12):1545-9. PubMed ID: 22129181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening properties of human papillomavirus testing for predicting cervical intraepithelial neoplasia in atypical squamous cells of undetermined significance and low-grade squamous intraepithelial lesion smears: a prospective study.
    Dane C; Batmaz G; Dane B; Cetin A
    Ann Diagn Pathol; 2009 Apr; 13(2):73-7. PubMed ID: 19302953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of human papillomavirus type 16/18 genotyping in predicting high-grade cervical/vaginal intraepithelial neoplasm in women with mildly abnormal Papanicolaou results.
    Guo M; Gong Y; Wang J; Dawlett M; Patel S; Liu P; Bevers TB; Sneige N
    Cancer Cytopathol; 2013 Feb; 121(2):79-85. PubMed ID: 23225501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined p16INK4a and human papillomavirus testing improves the prediction of cervical intraepithelial neoplasia (CIN II-III) in Thai patients with low-grade cytological abnormalities.
    Ekalaksananan T; Pientong C; Kongyingyoes B; Chaiwongkot A; Yuenyao P; Kleebkaow P; Kritpetcharat O; Evans MF
    Asian Pac J Cancer Prev; 2011; 12(7):1777-83. PubMed ID: 22126564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A prospective study of women with ASCUS or LSIL pap smears at baseline and HPV E6/E7 mRNA positive: a 3-year follow-up.
    Bruno MT; Ferrara M; Fava V; Barrasso G; Panella MM
    Epidemiol Infect; 2018 Apr; 146(5):612-618. PubMed ID: 29465024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CINtec® PLUS dual immunostain: a triage tool for cervical pap smears with atypical squamous cells of undetermined significance and low grade squamous intraepithelial lesion.
    Loghavi S; Walts AE; Bose S
    Diagn Cytopathol; 2013 Jul; 41(7):582-7. PubMed ID: 22833355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation of High-Risk HPV Genotypes with Pap Test Findings: A Retrospective Study in Eastern Province, Saudi Arabia.
    Kussaibi H; Al Dossary R; Ahmed A; Muammar A; Aljohani R
    Acta Cytol; 2021; 65(1):48-55. PubMed ID: 32784299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicting CIN2+ when detecting HPV mRNA and DNA by PreTect HPV-proofer and consensus PCR: A 2-year follow-up of women with ASCUS or LSIL Pap smear.
    Molden T; Nygård JF; Kraus I; Karlsen F; Nygård M; Skare GB; Skomedal H; Thoresen SO; Hagmar B
    Int J Cancer; 2005 May; 114(6):973-6. PubMed ID: 15645423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utility of human papillomavirus L1 capsid protein and HPV test as prognostic markers for cervical intraepithelial neoplasia 2+ in women with persistent ASCUS /LSIL cervical cytology.
    Ki EY; Park JS; Lee A; Kim TJ; Jin HT; Seo YB; Gen Y; Park MY; Lee SJ
    Int J Med Sci; 2019; 16(8):1096-1101. PubMed ID: 31523171
    [No Abstract]   [Full Text] [Related]  

  • 19. HPV detection rates and histopathologic follow-up of patients with HSIL cytology in a large academic women's hospital laboratory.
    Ashman D; Zhang H; Li J; Austin M; Wang T; Pradhan D; Zhao C
    J Am Soc Cytopathol; 2020; 9(6):550-555. PubMed ID: 32475726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human papillomavirus viral load in predicting high-grade CIN in women with cervical smears showing only atypical squamous cells or low-grade squamous intraepithelial lesion.
    Santos AL; Derchain SF; Martins MR; Sarian LO; Martinez EZ; Syrjänen KJ
    Sao Paulo Med J; 2003 Nov; 121(6):238-43. PubMed ID: 14989139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.